Your Search Results

TAVI in bicuspid aortic valves: optimal technique and procedural refinement

21 Nov 2021 – From PCR London Valves 2021

Framed around a "live-in-a-box" case performed in Toulouse, the core of this session will be on procedural technique: how do you best perform a TAVI to get optimal outcomes in bicuspid anatomy? It will also focus on preprocedural planning, and in particular CT image analysis, and detail...

TAVI in bicuspid aortic valves: optimal technique and procedural refinement

Transcatheter tricuspid valve replacement

21 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, discuss the new techniques available, selection criteria, and challenges encountered with this new procedure of transcatheter tricuspid valve replacement, and learn how you can train for these procedures with patient-specific simulators.

Transcatheter tricuspid valve replacement

Aortic stenosis in the younger patient: procedural complications and lifetime management

21 Nov 2021 – From PCR London Valves 2021

Biological, surgical valves and TAVIs are being implanted in younger and younger patients. Since these procedures must be planned in the best possible way to minimize future complications, and because the lifetime management of these patients must be thought of, watch this session to get very useful...

Aortic stenosis in the younger patient: procedural complications and lifetime management

Tricuspid transcatheter edge-to-edge repair

21 Nov 2021 – From PCR London Valves 2021

This session from PCR London Valves 2021 will focus on the most commonly performed tricuspid procedure: transcatheter edge-to-edge. Review the two technologies currently available, learn tips and tricks, share your experience, and examine all aspects, including imaging.

Tricuspid transcatheter edge-to-edge repair

Tricuspid valve disease: diagnosis and treatment selection

22 Nov 2021 – From PCR London Valves 2021

Presented during PCR London Valves 2021, view the case of an 85-year-old patient with hypertension, diabetes, and dyslipidemia, who has permanent atrial fibrillation and renal failure, but no left-sided valvular heart disease and follow the debates around which treatments to adopt!

Tricuspid valve disease: diagnosis and treatment selection

Aortic valve disease: state-of-the-art

22 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session begins with important updates on the seminal trials that have defined our TAVI era over the past decade before moving on to new studies that are very likely to shape the evolution of TAVI in the next ten years.

Mitral anatomy and imaging essentials

22 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, let's review the mitral anatomy from different standpoints before focusing on both mitral and transseptal punctures; then, let's try to transfer this knowledge into real practice by simulating some steps of these procedures.

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.